Back to mobile site

Aprea Therapeutics (APRE) Misses Q2 EPS by 53c

August 12, 2025 8:29 AM EDT

Aprea Therapeutics (NASDAQ: APRE) reported Q2 EPS of ($0.53).

For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK